Cited by 273Menopause: Health Impacts and TreatmentsOvarian function and disordersHormonal and reproductive studies

The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.

Cardiovascular disease risk in women with premature ovarian insufficiency: A systematic review and meta-analysis

Roeters van Lennep, Jeanine E, Heida, Karst Y, Bots, Michiel L, Hoek, Annemieke, on behalf of the collaborators of the Dutch Multidisciplinary Guideline Development Group on Cardiovascular Risk Management after Reproductive Disorders·2016·European Journal of Preventive Cardiology

DOI 10.1177/2047487314556004

Open this paper in CoChat — free account

Abstract

AIMS: The purpose of this review was to assess the relationship between premature ovarian insufficiency (POI), defined as natural menopause <40 years, and risk of ischaemic heart disease (IHD), stroke and overall cardiovascular disease (CVD). METHODS AND RESULTS: We performed a systematic search in PubMed (1966-2012), EMBASE (1980-2012). Studies were included if they were prospective, follow-up>3 years, assessment of age menopause <40 years, and incident cases of fatal or nonfatal IHD, stroke, or overall CVD. Relative risks (RRs) and 95% confidence interval (CI) were pooled using a random-effect model. Overall, 10 observational studies were identified, comprising 190,588 women (follow-up 4-37 years) with 9440 events (2026 events for IHD (seven studies) and 6438 events for stroke (seven studies) and 976 for total CVD (two studies). POI was assessed by questionnaire and incident cases through certification and event registers. POI was related to an increased risk of developing or dying from IHD (hazard ratio (HR) 1.69, 95% CI 1.29-2.21, p = 0.0001) and total CVD (HR 1.61, 95% CI 1.22-2.12, p = 0.0007). No relation was found for stroke (HR 1.03, 0.88-1.19, p = 0.74). We found no evidence for heterogeneity. CONCLUSION: POI is an independent though modest risk factor of IHD and overall CVD but not of stroke. Because of the limited impact of POI on CVD risk compared to classical cardiovascular risk factors, it is unlikely that POI will be implemented as modifier of cardiovascular risk classification.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1177/2047487314556004

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Quantifying heterogeneity in a meta‐analysis
Higgins, J. P. T., & Thompson, S. G. (2002) · Statistics in Medicine · doi:10.1002/sim.1186 · Cited by 36,763
Meta-analysis of Observational Studies in Epidemiology<SUBTITLE>A Proposal for Reporting</SUBTITLE>
Stroup, D. F. (2000) · JAMA · doi:10.1001/jama.283.15.2008 · Cited by 20,623
Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study
Yusuf, S., Hawken, S., Ôunpuu, S., Dans, T., Avezum, A., Lanas, F., McQueen, M., Budaj, A., Pais, P., Varigos, J., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17018-9 · Cited by 12,026
The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions.
Downs, S. H., & Black, N. (1998) · Journal of Epidemiology and Community Health · doi:10.1136/jech.52.6.377 · Cited by 8,252
Defining and Setting National Goals for Cardiovascular Health Promotion and Disease Reduction: The American Heart Association’s Strategic Impact Goal Through 2020 and Beyond
Lloyd-Jones, D. M., Hong, Y., Labarthe, D., Mozaffarian, D., Appel, L. J., Van Horn, L., Greenlund, K., Daniels, S., Nichol, G., Tomaselli, G. F., et al. (2010) · Circulation · doi:10.1161/circulationaha.109.192703 · Cited by 4,750
Primary Ovarian Insufficiency
Nelson, L. M. (2009) · New England Journal of Medicine · doi:10.1056/nejmcp0808697 · Cited by 1,189
Primary ovarian insufficiency
Vos, M. D., Devroey, P., & Fauser, B. C. J. M. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60355-8 · Cited by 781
Postmenopausal status and early menopause as independent risk factors for cardiovascular disease: a meta-analysis
Atsma, F., Bartelink, M.-L. E. L., Grobbee, D. E., & van der Schouw, Y. T. (2006) · Menopause · doi:10.1097/01.gme.0000218683.97338.ea · Cited by 744
Prevalence, incidence, diagnostic delay, and mortality in Turner syndrome
Stochholm, K., Juul, S., Juel, K., Naeraa, R. W., & Højbjerg Gravholt, C. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0558 · Cited by 652
Age at menopause as a risk factor for cardiovascular mortality
van der Schouw, Y. T., van der Graaf, Y., Steyerberg, E. W., Eijkemans, M. J. C., & Banga, J. D. (1996) · The Lancet · doi:10.1016/s0140-6736(96)90075-6 · Cited by 616

Show all 31 references

Sorted by citations

Items 201–273 of 273

Immune cytokines as a bridge linking the gut–liver–ovary axis in the pathogenesis of premature ovarian failure
Xu, H., Li, M., Yang, S., & Jiang, D. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1758707 · Cited by 1
Enhanced predictive performance of artificial intelligence in individualized ovarian stimulation of in vitro fertilization: a retrospective cohort study
Wang, G., Tang, M., Zhou, L., Li, F., Hu, X., Yu, Y., Ying, H., Chew, I., Zhu, K., & Zhu, Y. (2026) · BMC Medicine · doi:10.1186/s12916-026-04769-0 · Cited by 2
The risk for the development of hypertensive complications in oocyte donation pregnancy: a systematic review and individual participant data meta-analysis (DONOR IPD)
van Bentem, K., van der Hoorn, M., Banker, M., de la Calle, M., Elenis, E., Demellawy, D. E., Fox, N. S., Jeve, Y. B., Korb, D., Letur, H., et al. (2026) · Human Reproduction Update · doi:10.1093/humupd/dmag006 · Cited by 1
The Cardiometabolic Effects of Menopause
Karam, J., Lau, E. S., & SHUFELT, C. L. (2026) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000006418 · Cited by 1
Relation between platelet coagulant and vascular function, sex-specific analysis in adult survivors of childhood cancer compared to a population-based sample
Panova‐Noeva, M., Wagner, B., Nagler, M., Arnold, N., Prochaska, J. H., Eckerle, S., Spronk, H. M. H., Merzenich, H., Wingerter, A., Schneider, A., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-56626-1 · Cited by 1
Primary Prevention and Cardiovascular Risk Assessment in Women
Peterson, L.-A., Freaney, P. M., & Gulati, M. (2022) · Contemporary cardiology · doi:10.1007/978-3-030-98824-1_10 · Cited by 1
What Does the Data Show for Primary Ovarian Insufficiency?
Özcan, P., Parasar, P., & Fıçıcıoğlu, C. (2017) · Current Obstetrics and Gynecology Reports · doi:10.1007/s13669-017-0191-5 · Cited by 1
Premature Ovarian Insufficiency: Practical Management Approaches
Tsiligiannis, S., Panay, N., & Stevenson, J. C. (2019) · ISGE series · doi:10.1007/978-3-030-14358-9_11 · Cited by 1
Primaire ovariële insufficiëntie
Salwegter, M. H. E. (2019) · Praktische huisartsgeneeskunde · doi:10.1007/978-90-368-2409-5_11 · Cited by 1
PREMATURE OVARIAN FAILURE, ITS CONSEQUENCES, MORTALITY AND IMPACT ON THE CARDIOVASCULAR SYSTEM
Lopukhov, S. V., & Филиппов, Е. В. (2021) · Nauka molodykh (Eruditio Juvenium) · doi:10.23888/hmj202191147-156 · Cited by 1
Frequently Asked Questions About the Menopause
Löfqvist, H. (2022) · Springer eBooks · doi:10.1007/978-3-030-92735-6_10 · Cited by 1
Five Different Women and Problems to Solve During Menopause
Löfqvist, H. (2022) · Springer eBooks · doi:10.1007/978-3-030-92735-6_9 · Cited by 1
Clinical manifestations of decreased ovarian reserve in premenopausal women: a cross-sectional study
Salimova, M. D., Николаевна, Д. И., Nadelyaeva, Y., Лазарева, Л. М., Atalyan, A. V., Novikova, E. A., Sholokhov, L. F., Рашидова, М. А., & Сутурина, Л. В. (2022) · Экология человека · doi:10.17816/humeco106718 · Cited by 1
The Resistant Ovary Syndrome
Hachem, H. E., & Grynberg, M. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.95862-8 · Cited by 1
Ovarian Control of Maternal Cardiovascular Function
Thilaganathan, B. (2019) · Hypertension · doi:10.1161/hypertensionaha.119.13167 · Cited by 1
Premature Ovarian Insufficiency: Advances in Management Through a Global Registry
Panay, N. (2015) · ISGE series · doi:10.1007/978-3-319-23865-4_7
Current Resources for Evidence-Based Practice, March/April 2017
Kern, M., & Carlson, N. S. (2017) · Journal of Obstetric, Gynecologic & Neonatal Nursing · doi:10.1016/j.jogn.2017.01.004
Primary Ovarian Insufficiency/Premature Ovarian Failure: Management Considerations and Strategies
Santoro, N. F. (2017) · Springer eBooks · doi:10.1007/978-3-319-42451-4_13
Management der prämaturen Ovarialinsuffizienz
Weidlinger, S., & Stute, P. (2018) · Gynäkologische Endokrinologie · doi:10.1007/s10304-018-0201-3
Hormone Replacement Therapy in Premature Ovarian Insufficiency
Bruni, V., & Pampaloni, F. (2019) · ISGE series · doi:10.1007/978-3-030-14358-9_10 · Cited by 1
Premature Ovarian Insufficiency
Podfigurna, A., Grymowicz, M., Szeliga, A., Rudnicka, E., Maciejewska-Jeske, M., Smolarczyk, R., & Męczekalski, B. (2019) · Springer eBooks · doi:10.1007/978-3-030-13936-0_3
Premature ovariële insufficiëntie of premature onrust?
Sliedrecht, A., & Lagro‐Janssen, T. (2020) · Huisarts en Wetenschap · doi:10.1007/s12445-020-0797-0
Sex Differences in Young Adults Who Experience Myocardial Infarction
DeFilippis, E. M., Wu, W. Y., Lau, E. S., Blankstein, R., & Divakaran, S. (2020) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-020-00870-6
Risk and possibilities of preventing cardiovascular diseases in women in peri- and postmenopause
Kuznetsova, I. V. (2019) · Medical alphabet · doi:10.33667/2078-5631-2019-2-14(389)-6-14
Oft gestellte Fragen zu den Wechseljahren
Löfqvist, H. (2021) · Springer eBooks · doi:10.1007/978-3-662-62710-5_9
ANALYSIS OF CARDIOVASCULAR RISK AND ADVERSE OUTCOMES IN WOMEN WITH PREMATURE OVARIAN INSUFFICIENCY COMPARED WITH HEALTHY WOMEN
Lopukhov, S. V., & Филиппов, Е. В. (2021) · Современные проблемы науки и образования · doi:10.17513/spno.31047
Review of menopause advice given to patients undergoing bilateral oophorectomy
Elson, J., Bruce, D., Holloway, D., & RYMER, J. M. (2021) · Post Reproductive Health · doi:10.1177/20533691211058518 · Cited by 1
Associations of blood biomarkers and structural changes in atherosclerosis in the Longitudinal study of adult heath (Elsa-Brasil): emphasis on pre-and postmenopausal women
Fonseca, M. I. H. (2021) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.6.2021.tde-29122021-150846
Prämature Ovarialinsuffizienz
Weidlinger, S. (2018) · Journal für Gynäkologische Endokrinologie/Schweiz · doi:10.1007/s41975-018-0045-1
Assessment of left ventricular myocardial systolic dysfunction in premature ovarian insufficiency using echocardiographic layer-specific myocardial strain imagingPreprint
Wang, Y., Yin, L., & Li, M. (2020) · doi:10.22541/au.160467860.08707066/v1
The role of nurse practitioners in primary care in optimizing risk stratification for coronary heart disease in Canadian women: an integrative review
Sangha, P. (2017) · doi:10.24124/2017/1383
Primary Ovarian Insufficiency
Persani, L. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.95860-4 · Cited by 2
Bibliographies
(2020) · Springer Publishing Company eBooks · doi:10.1891/9780826173270.ap08
The Link Between Reproductive History, Cardiovascular Disease, and Peripheral Arterial Disease in Women: Implications for Practice
Lemoine, J., & Wilson, B. L. (2023) · The Journal for Nurse Practitioners · doi:10.1016/j.nurpra.2022.12.001
Fallo ovárico, una problemática para las mujeres en edad reproductiva y su relación genética
Jaramillo, L. I. J., Roldán-Tabares, M. D., Palacio, S. C., & Sánchez, L. M. M. (2023) · Clínica e Investigación en Ginecología y Obstetricia · doi:10.1016/j.gine.2023.100849
Vaginal Microbiome of Women with Premature Ovarian Insufficiency - Descriptive cross-sectional studyPreprint
Rezende, G. P., Giraldo, H., Giraldo, P. C., de Mira, T. A. A., Yela, D. A., do Amaral, R. L. G., & Benetti‐Pinto, C. L. (2023) · doi:10.22541/au.167914800.00982976/v1
Menopause
Goyal, A., Gupta, P., & Sturdee, D. W. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-99967-0.00010-7
Menopause and the Bridge to Cardiovascular Disease
Rouhana, S., & Pyle, W. G. (2023) · Advances in biochemistry in health and disease · doi:10.1007/978-3-031-39928-2_10 · Cited by 1
Ovarian reserve and fertility preservation
Tu, W., Guo, Z., He, B., Wang, H., & Yan, L. (2023) · Scientia Sinica Vitae · doi:10.1360/ssv-2023-0165
Influência da corrente interferencial na função sexual e microbioma de mulheres com insuficiência ovariana prematura
Souza, H. P. D. G. (2019) · doi:10.47749/t/unicamp.2019.1166833
Long-Term Health Consequences and Management Considerations of Premature Ovarian Insufficiency
Li, X. (2024) · Advances in Clinical Medicine · doi:10.12677/acm.2024.1441342
Assessment of cardiovascular risk in women with premature ovarian failure
Lopukhov, S. V., & Filippov, E. V. (2024) · Kazan medical journal · doi:10.17816/kmj508732
Late adverse effects of treatment in female survivors of Hodgkin lymphoma
Krul, I. M. (2024) · doi:10.5463/thesis.765
Dyslipidemia in Women
van Lennep, J. E. R., & Holven, K. B. (2024) · Springer eBooks · doi:10.1007/978-3-031-65952-2_5
Cycle Abnormalities and Cardiometabolic Health
Daan, M. P. N., Maas, A. H. E. M., & Fauser, B. C. J. M. (2024) · Springer eBooks · doi:10.1007/978-3-031-65952-2_9
Is Preventative Oophorectomy Safe?
Tesch, M. E., Drachman, D. E., & Mayer, E. L. (2024) · JACC CardioOncology · doi:10.1016/j.jaccao.2024.11.001
Advances of Biological Therapies in Premature Ovarian Insufficiency
赵, 铭. (2025) · Advances in Clinical Medicine · doi:10.12677/acm.2025.1541185
Menopausal Hormone Therapy and Prevention of Chronic Disease
Mauvais‐Jarvis, F., & Lovre, D. (2025) · Springer eBooks · doi:10.1007/978-3-031-89650-7_3
Premature ovarian insufficiency: An update. A literature review
Abdelhafez, M. M., Ahmed, K. A. M., Ahmed, N. A. M., Ismail, M. H., Daud, M. N., Eldiasty, A., Amri, M. F., Jeffree, M. S., Kadir, F., Baharuddin, D. M. P., et al. (2025) · Clínica e Investigación en Ginecología y Obstetricia · doi:10.1016/j.gine.2025.101071
Correlation between anti-Müllerian hormone, hypertension and vascular age: the Generation R Study, a population-based prospective cohort study
Dykgraaf, R., Schalekamp–Timmermans, S., van den Berg, S. A. A., Vinke, E. J., Steegers, E., Laven, J. S. E., & Louwers, Y. V. (2025) · Maturitas · doi:10.1016/j.maturitas.2025.108785
Women’s Cardiovascular Health: A Distinct Paradigm
Rodriguez, A. P., & Vicenty-Rivera, S. I. (2025) · Cardiology and cardiovascular medicine. · doi:10.5772/intechopen.1013549 · Cited by 1
Symptom Patterns in Premature Ovarian Insufficiency Differ Across Age of Diagnosis and Aetiology: Implications for Neural Mechanisms and Brain HealthPreprint
Naysmith, L. F. (2025) · Research Square · doi:10.21203/rs.3.rs-8280682/v1
Additional file 1 of Metabolic differences in women with premature ovarian insufficiency: a systematic review and meta-analysis
Cai, W.-Y., Luo, X., Wu, W., Song, J., Xie, N.-N., Duan, C., Wu, X.-K., & Xu, J. (2022) · Figshare · doi:10.6084/m9.figshare.21256864
Additional file 3 of Metabolic differences in women with premature ovarian insufficiency: a systematic review and meta-analysis
Cai, W.-Y., Luo, X., Wu, W., Song, J., Xie, N.-N., Duan, C., Wu, X.-K., & Xu, J. (2022) · Figshare · doi:10.6084/m9.figshare.21256870
Additional file 2 of Metabolic differences in women with premature ovarian insufficiency: a systematic review and meta-analysis
Cai, W.-Y., Luo, X., Wu, W., Song, J., Xie, N.-N., Duan, C., Wu, X.-K., & Xu, J. (2022) · Figshare · doi:10.6084/m9.figshare.21256867
Additional file 1 of Prevalence of premature ovarian insufficiency and its determinants in Iranian populations: Tehran lipid and glucose study
Dovom, M. R., ‌Bidhendi-Yarandi, R., Mohammad, K., Farahmand, M., Azizi, F., & Ramezani Tehrani, F. (2021) · Figshare · doi:10.6084/m9.figshare.14100612
Additional file 4 of Metabolic differences in women with premature ovarian insufficiency: a systematic review and meta-analysis
Cai, W.-Y., Luo, X., Wu, W., Song, J., Xie, N.-N., Duan, C., Wu, X.-K., & Xu, J. (2022) · Figshare · doi:10.6084/m9.figshare.21256873
Additional file 1 of Combined effect of menopause and cardiovascular risk factors on death and cardiovascular disease: a cohort study
Li, Y., Zhao, D., Wang, M., Sun, J.-Y., Liu, J., Qi, Y., Hao, Y.-C., Deng, Q.-J., Liu, J., Liu, J., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14100526
Primary ovarian insufficiency
Persani, L., Federici, S., & Dorato, E. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-13825-6.00370-8
Architecture génétique de l'insuffisance ovarienne primitive : Nouveaux liens avec les Gènes de Méiose/Réparation de l’ADN, nouvelles voies moléculaires identifiées et implication pour une Médecine Personnalisée
Heddar, A. (2022) · doi:10.70675/fa7aeccbzb305z4eebz84b7z1ecc809ff42d
Early and Premature Menopause as Cardiovascular Disease Risk-Enhancing Factors
Rana, M., Kapoor, E., & Honigberg, M. C. (2026) · Springer eBooks · doi:10.1007/978-3-032-18203-6_6
Ceramide: a pivotal lipid mediator shaping female reproductive homeostasis and pathophysiology
Wang, W., Zhang, F., Huang, L., Qiao, J., & Qi, X. (2026) · Journal of Ovarian Research · doi:10.1186/s13048-026-02169-9
Lipids in women: lifelong risk assessment
Pavlyha, M., Welty, F. K., & Reyes‐Soffer, G. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-45863-7.00058-5
Premature Ovarian Insufficiency
Jovanovic, M., Laufer, A. B., & Gordon, C. M. (2026) · Springer eBooks · doi:10.1007/978-3-032-19887-7_9
Premature ovarian insufficiency: Evidence–practice gaps and key management challenges among clinicians
Langhe, R., Ibrahim, R., Umar, R., Kelly, T., Greene, K., Seshan, V., Mahmoud, I., Mohammed, G., & Mousa, N. A. (2026) · Maturitas · doi:10.1016/j.maturitas.2026.109055 · Cited by 1
Premature Ovarian Insufficiency in a Patient With Vogt–Koyanagi–Harada Syndrome: An Unusual Association—A Case Report
Rocha, R. B., Benzaquem, D. C., Passos, P. D. S., da Silva, E. K. C., Mendonça, J. B., da Silva, P. R. L., Ferreira, J. F. B., & Fantin, C. (2026) · Case Reports in Medicine · doi:10.1155/carm/2727070
Cardiovascular Effects of Sex Hormones and Their Receptors
Molezini, L., Xia, W., & Khalil, R. A. (2026) · Physiology in health and disease · doi:10.1007/978-3-032-26472-5_6
Long-term systemic outcomes of postmenopausal hormone replacement therapy by age at menopause: a real-world cohort study
Lu, T.-F., Lu, C., Shih, Y., Chen, Y., Fan, C.-T., Wang, S.-J., Hsu, S., Liu, C.-K., Sun, L., Hwang, S.-F., et al. (2026) · Human Reproduction Open · doi:10.1093/hropen/hoag072
Role of menopause in the development of cardiovascular disease in women
Das, S., Wang, W., & Kunadian, V. (2026) · Open Heart · doi:10.1136/openhrt-2026-004200
Menopause Hormone Therapy in Women With Cardiovascular Risk Factors or Established Ischemic Heart Disease: A Joint FIGO and WHF Position Paper
Benedetto, C., Gulati, M., Khadilkar, S. S., Maas, A. H. E. M., Frezet, F., de Oliveira, G. M. M., Genazzani, A. R., Divakar, H., & Poppas, A. (2026) · Global Heart · doi:10.5334/gh.1576
Menopause hormone therapy in women with cardiovascular risk factors or established ischemic heart disease: A joint FIGO and WHF position paper
Benedetto, C., Gulati, M., Khadilkar, S. S., Maas, A. H. E. M., Frezet, F., de Oliveira, G. M. M., Genazzani, A. R., Divakar, H., Poppas, A., & the World Heart Federation (WHF) and the International Federation of Gynecology and Obstetrics (FIGO) (2026) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.71356
From Menarche to Menopause: Why Reproductive History Matters for Cardiovascular Risk Assessment
Adebowale, O. N., & Zakaria, S. (2026) · Journal of the American Heart Association · doi:10.1161/jaha.126.054211
Translational Perspectives on Cardiac Diseases Disproportionately Affecting Women
Mygind, N. D., Asiki, G., Cupido, B. J., Gliemann, L., Haugaa, K. H., Hellsten, Y., Linde, C. M., Nyegaard, M., Ömerovic, E., Roy, A., et al. (2026) · Journal of the American Heart Association · doi:10.1161/jaha.126.050650

Authors: Roeters van Lennep, J. E., Heida, K. Y., Bots, M. L., Hoek, A., & on behalf of the collaborators of the Dutch Multidisciplinary Guideline Development Group on Cardiovascular Risk Management after Reproductive Disorders
Affiliations: Department of Internal Medicine, Erasmus MC, the Netherlands
University Medical Center Utrecht (NL)
University of Groningen (NL)
ORCID: Bots, Michiel L
Hoek, Annemieke
Venue: European Journal of Preventive Cardiology
Publisher: Oxford University Press (OUP)
Published: 2014-10-20
Volume: 23
Issue: 2
Pages: 178-186
ISSN: 2047-4873 (ISSN-L)
2047-4881
DOI: 10.1177/2047487314556004
OpenAlex: W2120592625
Cited by: 273
References: 31
Citations by year: 2026: 24 · 2025: 29 · 2024: 23 · 2023: 29 · 2022: 34 · 2021: 25 · 2020: 24 · 2019: 29 · 2018: 21 · 2017: 16 · 2016: 7 · 2015: 11 · 2014: 1
FWCI: 1.86
Type: journal article
Language: en
Open access: closed
Licence: journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
Locations: European Journal of Preventive Cardiology (publishedVersion)
PubMed (publishedVersion)
EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion)
Utrecht University Repository (Utrecht University) (submittedVersion)
Topics: Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
Keywords: premature ovarian insufficiency, cardiovascular risk, ischemic heart disease, stroke, women, natural menopause, cardiovascular risk factors, cardiovascular risk classification
MeSH terms: Cardiovascular Diseases, Female, Humans, Risk Factors, Primary Ovarian Insufficiency, Stroke

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Cardiovascular disease risk in women with premature ovarian insufficiency: A systematic review and meta-analysis

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks